| RS28928909 |
MYF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant centronuclear myopathy, MYF6-related disorder |
| RS28928910 |
NEFL
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 1C |
| RS28929469 |
SERPINC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS28929470 |
SERPINA1
|
Health Risk |
Conflicting classifications of pathogenicity |
PI F, Alpha-1-antitrypsin deficiency |
| RS28929474 |
SERPINA1
|
Health Risk |
Likely pathogenic |
PI Z, PI Z(AUGSBURG) |
| RS28929478 |
ATP2A2
|
Health Risk |
Pathogenic |
Keratosis follicularis, Keratosis follicularis |
| RS28929479 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS28929480 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 4, Cryohydrocytosis |
| RS28929483 |
MSH2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome |
| RS28929484 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome |
| RS28929485 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal dominant keratitis-ichthyosis-hearing loss syndrome, Autosomal dominant keratitis-ichthyosis-hearing loss syndrome |
| RS28929488 |
SERPINA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Corticosteroid-binding globulin deficiency, SERPINA6-related disorder |
| RS28929498 |
FAS
|
Health Risk |
Pathogenic |
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA |
| RS28929768 |
CHRNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4C |
| RS28930068 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS28930069 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS28931568 |
SERPINA1
|
Health Risk |
Pathogenic; other |
PI M(MINERAL SPRINGS), Alpha-1-antitrypsin deficiency |
| RS28931569 |
SERPINA1
|
Health Risk |
Pathogenic/Likely pathogenic |
PI M(PROCIDA), Alpha-1-antitrypsin deficiency |
| RS28931570 |
SERPINA1
|
Health Risk |
Pathogenic/Likely pathogenic |
PI I, Alpha-1-antitrypsin deficiency |
| RS28931572 |
SERPINA1
|
Health Risk |
Pathogenic; other |
PI Q0(LUDWIGSHAFEN), PI NULL(LUDWIGSHAFEN) |
| RS28931573 |
APOA1
|
Health Risk |
Pathogenic |
APOLIPOPROTEIN A-I (MILANO), APOLIPOPROTEIN A-I (MILANO) |
| RS28931574 |
APOA1
|
Health Risk |
Pathogenic |
Familial amyloid polyneuropathy, Iowa type |
| RS28931578 |
APOE
|
Health Risk |
Pathogenic |
APOE2 VARIANT, APOE2 VARIANT |
| RS28931580 |
AQP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Diabetes insipidus, nephrogenic |
| RS28931581 |
NPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Acromesomelic dysplasia 1, Maroteaux type |
| RS28931582 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS28931583 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS28931584 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 4, Renal tubular acidosis |
| RS28931585 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS28931586 |
CD40
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS28931588 |
CTNNB1
|
Health Risk |
Pathogenic |
Hepatoblastoma, Pilomatrixoma |
| RS28931589 |
CTNNB1
|
Health Risk |
Pathogenic; other |
Hepatoblastoma, Prostate cancer |
| RS28931591 |
CHRNA4
|
Health Risk |
Pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 1, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS28931593 |
GJB2
|
Health Risk |
Pathogenic |
Palmoplantar keratoderma-deafness syndrome, Autosomal dominant nonsyndromic hearing loss 3A |
| RS28931594 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal dominant keratitis-ichthyosis-hearing loss syndrome, Ichthyosis |
| RS28931595 |
GJB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 3A, Autosomal recessive nonsyndromic hearing loss 1A |
| RS28931600 |
GJA1
|
Health Risk |
Pathogenic |
Syndactyly type 3, Syndactyly type 3 |
| RS28931601 |
GJA1
|
Health Risk |
Pathogenic |
Oculodentodigital dysplasia, autosomal recessive |
| RS28931602 |
FBN2
|
Health Risk |
Pathogenic |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS28931603 |
CPOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Coproporphyria, Hereditary coproporphyria |
| RS28931604 |
CRYGC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 2, multiple types |
| RS28931605 |
CRYGD
|
Health Risk |
Pathogenic |
Cataract 4 multiple types, Developmental cataract |
| RS28931606 |
POR
|
Health Risk |
Pathogenic |
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis |
| RS28931607 |
POR
|
Health Risk |
Likely pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia |
| RS28931608 |
POR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis |
| RS28931609 |
CYP11B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Corticosterone methyl oxidase type II deficiency, Early-onset familial hypoaldosteronism |
| RS28931610 |
DSP
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS28931611 |
ELANE
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS28931612 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Parathyroid adenoma, somatic |
| RS28931613 |
TYMP
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 1, Mitochondrial DNA depletion syndrome 1 |
| RS28931614 |
FGFR3
|
Health Risk |
Pathogenic |
Achondroplasia, Epidermal nevus |
| RS28931615 |
FGFR3
|
Health Risk |
Pathogenic |
Crouzon syndrome-acanthosis nigricans syndrome, Craniosynostosis syndrome |
| RS28932180 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Sotos syndrome |
| RS28932470 |
POMC
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to pro-opiomelanocortin deficiency, Obesity |
| RS28932472 |
POMC
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity, early-onset |
| RS28932769 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS28933068 |
FGFR3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypochondroplasia, Achondroplasia |
| RS28933074 |
GNRHR
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 7 with or without anosmia, Hypogonadotropic hypogonadism 7 with or without anosmia |
| RS28933081 |
MSX1
|
Health Risk |
Pathogenic |
Orofacial cleft 5, Orofacial cleft 5 |
| RS28933082 |
HOXD13
|
Health Risk |
Pathogenic |
Synpolydactyly type 1, Brachydactyly type E1 |
| RS28933087 |
KRT6A
|
Health Risk |
Pathogenic |
Pachyonychia congenita 3, Pachyonychia congenita 3 |
| RS28933088 |
KRT17
|
Health Risk |
Pathogenic |
Pachyonychia congenita 2, Pachyonychia congenita 2 |
| RS28933089 |
KRT17
|
Health Risk |
Pathogenic |
Pachyonychia congenita 2, Pachyonychia congenita 2 |
| RS28933090 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS28933091 |
LMNA
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1A, Primary dilated cardiomyopathy |
| RS28933092 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1A, Primary dilated cardiomyopathy |
| RS28933093 |
LMNA
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1A, Primary dilated cardiomyopathy |
| RS28933098 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS28933100 |
NFKBIA
|
Health Risk |
Pathogenic |
Ectodermal dysplasia and immunodeficiency 2, Ectodermal dysplasia and immunodeficiency 2 |
| RS28933368 |
ERBB2
|
Health Risk |
Pathogenic |
Glioma susceptibility 1, Glioma susceptibility 1 |
| RS28933369 |
ERBB2
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS28933370 |
ERBB2
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS28933371 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism, Piebaldism |
| RS28933372 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, severe |
| RS28933373 |
PAX9
|
Health Risk |
Likely pathogenic |
Tooth agenesis, selective |
| RS28933374 |
PRF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis |
| RS28933375 |
PALD1;PRF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 2, Autoinflammatory syndrome |
| RS28933376 |
PRF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 2, Autoinflammatory syndrome |
| RS28933377 |
GP9
|
Health Risk |
Likely pathogenic |
Bernard-Soulier syndrome type C, Bernard Soulier syndrome |
| RS28933378 |
GP9
|
Health Risk |
Likely pathogenic |
Bernard-Soulier syndrome type C, Bernard Soulier syndrome |
| RS28933381 |
KCNA1
|
Health Risk |
Pathogenic |
Myokymia 1, Myokymia 1 |
| RS28933382 |
KCNA1
|
Health Risk |
Pathogenic |
Myokymia 1, Myokymia 1 |
| RS28933383 |
KCNA1
|
Health Risk |
Pathogenic |
Episodic ataxia type 1, Myokymia 1 |
| RS28933384 |
KCNE1
|
Health Risk |
Pathogenic |
Jervell and Lange-Nielsen syndrome 2, Congenital long QT syndrome |
| RS28933385 |
PRNP
|
Health Risk |
Pathogenic |
Inherited Creutzfeldt-Jakob disease, Fatal familial insomnia |
| RS28933386 |
PTPN11
|
Health Risk |
Pathogenic |
Noonan syndrome 1, RASopathy |
| RS28933389 |
BCHE
|
Health Risk |
Conflicting classifications of pathogenicity |
BCHE, flouride 1 |
| RS28933390 |
BCHE
|
Health Risk |
Conflicting classifications of pathogenicity |
BCHE, fluoride 2 |
| RS28933391 |
PDHB
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-beta deficiency, Pyruvate dehydrogenase E1-beta deficiency |
| RS28933392 |
RAG1
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, B cell-negative |
| RS28933394 |
RHO
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 4, Retinal dystrophy |
| RS28933395 |
RHO
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 4, Retinitis pigmentosa |
| RS28933396 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS28933398 |
ATP1A2
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS28933399 |
ATP1A2
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS28933400 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS28933401 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS28933402 |
SURF1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS28933405 |
TTN
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 9, Hypertrophic cardiomyopathy 9 |
| RS28933406 |
HRAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Thyroid cancer, nonmedullary |